New York State Common Retirement Fund’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-26
Closed -$283 3364
2023
Q2
$283 Sell
26
-2,106
-99% -$25.7K ﹤0.01% 3386
2023
Q1
$28.2K Hold
2,132
﹤0.01% 3078
2022
Q4
$26.9K Buy
2,132
+4
+0.2% +$198 ﹤0.01% 3157
2022
Q3
$206K Buy
2,128
+14
+0.7% +$1.6K ﹤0.01% 2760
2022
Q2
$195K Sell
2,114
-2,902
-58% -$411K ﹤0.01% 2814
2022
Q1
$1.08M Buy
5,016
+716
+17% +$167K ﹤0.01% 2073
2021
Q4
$1.47M Buy
4,300
+779
+22% +$301K ﹤0.01% 1933
2021
Q3
$1.26M Buy
3,521
+472
+15% +$176K ﹤0.01% 2013
2021
Q2
$1.18M Buy
3,049
+2,058
+208% +$763K ﹤0.01% 2148
2021
Q1
$497K Buy
+991
New +$508K ﹤0.01% 2469

Other funds holding TIL

New York State Common Retirement Fund's TIL Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of Instil Bio (TIL) in Q3 2023, closing a stake of 26 shares — an estimated $283 sold.

New York State Common Retirement Fund first reported a position in TIL in Q1 2021 and held it in 10 quarters. The position peaked at $1.47M in Q4 2021. 58 funds tracked by Wall St. Rank hold TIL as of Q3 2023.

  • New York State Common Retirement Fund reported no remaining Instil Bio position as of Q3 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 26 Instil Bio shares in Q3 2023, an estimated $283.
  • New York State Common Retirement Fund first reported a position in Instil Bio in Q1 2021 and held it in 10 quarters.
  • New York State Common Retirement Fund's Instil Bio position peaked at $1.47M in Q4 2021.
  • 58 funds tracked by Wall St. Rank held Instil Bio as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.